Maura Statzu1, Letizia Santinelli1, Agnese Viscido1, Claudia Pinacchio2, Giancarlo Ceccarelli2, Claudia Rotondo1, Giuseppe Corano Scheri2, Ivano Mezzaroma3, Ombretta Turriziani1, Guido Antonelli1, Gabriella d'Ettorre2, Carolina Scagnolari4. 1. Laboratory of Virology, Department of Molecular Medicine, Affiliated to Istituto Pasteur Italia, Cenci Bolognetti Foundation, Sapienza University of Rome, Rome, Italy. 2. Department of Public Health and Infectious Diseases, Sapienza University of Rome, Policlinico Umberto I, Viale del Policlinico 155, 00161, Rome, Italy. 3. Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy. 4. Laboratory of Virology, Department of Molecular Medicine, Affiliated to Istituto Pasteur Italia, Cenci Bolognetti Foundation, Sapienza University of Rome, Rome, Italy. carolina.scagnolari@uniroma1.it.
Abstract
PURPOSE: To investigate the contribution of SAMHD1 to HIV-1 infection in vivo and its relationship with IFN response, the expression of SAMHD1 and IFN-related pathways was evaluated in HIV-1-infected patients. METHODS: Peripheral blood mononuclear cells (PBMC) from 388 HIV-1-infected patients, both therapy naïve (n = 92) and long-term HAART treated (n = 296), and from 100 gender and age-matched healthy individuals were examined. CD4+ T cells, CD14+ monocytes and gut biopsies were also analyzed in HIV-1-infected subjects on suppressive antiretroviral therapy. Gene expression levels of SAMDH1, ISGs (MxA, MxB, HERC5, IRF7) and IRF3 were evaluated by real-time RT-PCR assays. RESULTS: SAMHD1 levels in HIV-1-positive patients were significantly increased compared to those in healthy donors. SAMHD1 expression was enhanced in treated patients compared to naïve patients (p < 0.0001) and healthy donors (p = 0.0038). Virologically suppressed treated patients exhibited higher SAMHD1 levels than healthy donors (p = 0.0008), viraemic patients (p = 0.0001) and naïve patients (p < 0.0001). SAMHD1 levels were also increased in CD4+ T cells compared to those in CD14+ monocytes and in PBMC compared to those of GALT. Moreover, SAMHD1 was expressed more strongly than ISGs in HIV-1-infected patients and positive correlations were found between SAMHD1, ISGs and IRF3 levels. CONCLUSIONS: SAMHD1 is more strongly expressed than the classical IFN-related genes, increased during antiretroviral therapy and correlated with ISGs and IRF3 in HIV-1-infected patients.
PURPOSE: To investigate the contribution of SAMHD1 to HIV-1 infection in vivo and its relationship with IFN response, the expression of SAMHD1 and IFN-related pathways was evaluated in HIV-1-infected patients. METHODS: Peripheral blood mononuclear cells (PBMC) from 388 HIV-1-infected patients, both therapy naïve (n = 92) and long-term HAART treated (n = 296), and from 100 gender and age-matched healthy individuals were examined. CD4+ T cells, CD14+ monocytes and gut biopsies were also analyzed in HIV-1-infected subjects on suppressive antiretroviral therapy. Gene expression levels of SAMDH1, ISGs (MxA, MxB, HERC5, IRF7) and IRF3 were evaluated by real-time RT-PCR assays. RESULTS: SAMHD1 levels in HIV-1-positive patients were significantly increased compared to those in healthy donors. SAMHD1 expression was enhanced in treated patients compared to naïve patients (p < 0.0001) and healthy donors (p = 0.0038). Virologically suppressed treated patients exhibited higher SAMHD1 levels than healthy donors (p = 0.0008), viraemic patients (p = 0.0001) and naïve patients (p < 0.0001). SAMHD1 levels were also increased in CD4+ T cells compared to those in CD14+ monocytes and in PBMC compared to those of GALT. Moreover, SAMHD1 was expressed more strongly than ISGs in HIV-1-infected patients and positive correlations were found between SAMHD1, ISGs and IRF3 levels. CONCLUSIONS: SAMHD1 is more strongly expressed than the classical IFN-related genes, increased during antiretroviral therapy and correlated with ISGs and IRF3 in HIV-1-infected patients.
Authors: Alexandre Sze; S Mehdi Belgnaoui; David Olagnier; Rongtuan Lin; John Hiscott; Julien van Grevenynghe Journal: Cell Host Microbe Date: 2013-10-16 Impact factor: 21.023
Authors: Nicolas Ruffin; Vedran Brezar; Diana Ayinde; Cécile Lefebvre; Julian Schulze Zur Wiesch; Jan van Lunzen; Maximilian Bockhorn; Olivier Schwartz; Hakim Hocini; Jean-Daniel Lelievre; Jacques Banchereau; Yves Levy; Nabila Seddiki Journal: AIDS Date: 2015-03-13 Impact factor: 4.177
Authors: Sarah Schmidt; Kristina Schenkova; Tarek Adam; Elina Erikson; Judith Lehmann-Koch; Serkan Sertel; Bruno Verhasselt; Oliver T Fackler; Felix Lasitschka; Oliver T Keppler Journal: J Leukoc Biol Date: 2015-02-02 Impact factor: 4.962
Authors: Hangxing Yu; Shariq M Usmani; Alexandra Borch; Julia Krämer; Christina M Stürzel; Mohammad Khalid; Xuehua Li; Daniela Krnavek; Marchina E van der Ende; Albert D Osterhaus; Rob A Gruters; Frank Kirchhoff Journal: Retrovirology Date: 2013-03-05 Impact factor: 4.602
Authors: Y M El-Sherbiny; A Psarras; M Y Md Yusof; E M A Hensor; R Tooze; G Doody; A A A Mohamed; D McGonagle; M Wittmann; P Emery; E M Vital Journal: Sci Rep Date: 2018-04-11 Impact factor: 4.996